Skip to Content

Label Changes for:

Etopophos (etoposide phosphate) powder for injection

March 2011

Changes have been made to the WARNINGS sections of the safety label.

Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER) – March 2011




  • Injection site reactions may occur during the administration of Etopophos. Closely monitor the infusion site for possible infiltration during drug administration. No specific treatment for extravasation reactions is known.


  • Local soft tissue toxicity has been reported following extravasation of Etopophos.